A phase III confirmatory trial of belinostat in combination with cyclophosphamide, vincristine, doxorubicin and prednisone (CHOP) versus CHOP alone in patients with peripheral T-cell lymphoma
Phase of Trial: Phase III
Latest Information Update: 25 Oct 2016
Price : $35 *
At a glance
- Drugs Belinostat (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Vincristine
- Indications Peripheral T-cell lymphoma
- Focus Registrational; Therapeutic Use
- 25 Oct 2016 According to an Onxeo media release, this trial is expected to initiate during the end of 2016.
- 04 Mar 2015 According to Onxeo media release, company is planning to initiate this trial by first quarter of 2016.
- 30 Aug 2013 New trial record